Abstract
For a long time, oxytocin was regarded as a pregnancy hormone released by the hypophysis to stimulate labour and milk ejection. In the present survey, data have been collected from the literature to show the spectrum of the hitherto known functions of oxytocin outside pregnancy. It is now known that oxytocin receptors can occur almost ubiquitously in the organism, that oxytocin is also formed outside of the brain and that oxytocin has functions in a number of organs. In the first part of the survey, stimuli that contribute to an increase in oxytocin release are compiled. In the second part, details are given on the individual oxytocin targets. Although the majority of findings are based on the results of animal experiments, there are already a number of studies that indicate similar effects of oxytocin in humans. According to the current state of knowledge, oxytocin appears to be involved in functions in the following organs: male and non-pregnant female reproductive tract, pancreas, cardiovascular system, kidney, brain and breast. There are indications that oxytocin may also have actions in other organs. There continues to be a considerable need for research into oxytocin in order to better understand the physiological and pathophysiological actions and to be able to derive possible therapeutic uses. Further light on the spectrum of functions of oxytocin may be cast by the possibility of the use of oxytocin antagonists.
References
1.
Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Goodman MJ, Gilman A (eds): Goodman and Gilman’s The Pharmacological Basis of Therapeutics, ed 9. New York, McGraw-Hill Health Professions Division, 1996, pp 939–949.
2.
Du Vigneaud V, Ressler C, Swan JM, Robert CW, Katsoyannis PG, Gordon S: The synthesis of an octapeptide amide with the hormonal activity of oxytocin. J Am Chem Soc 1954;75;4879–4880.
3.
Cunningham FG, Mac Donald PC, Gant NF (eds): Williams Obstetrics, ed 20. London, Prentice Hall International, 1997, pp 294–296.
4.
Parker SL, Crowley WR: Central stimulation of oxytocin release in the lactating rat: Interaction of neuropeptide Y with alpha-1-adrenergic mechanisms. Endocrinology 1993;132:658–666.
5.
Parker SL, Crowley WR: Stimulation of oxytocin release in the lactating rat by a central interaction of alpha-1-adrenergic and alpha-amino-3-hydroxy-5-methylisoxazole-4-proprionic acid-sensitive excitatory amino acid mechanisms. Endocrinology 1993;133:2855–2860.
6.
Bealer SL, Crowley WR: Stimulation of central and systemic oxytocin release by histamine in the paraventricular hypothalamic nucleus: Evidence for an interaction with norepinephrine. Endocrinology 1999;140:1158–1164.
7.
Bagdy G, Arato M: Gender-dependent dissociation between oxytocin but not ACTH, cortisol or TSH response to m-chlorophenylpiperazine in healthy subjects. Psychopharmacology (Berl) 1998;136:342–348.
8.
Leng G, Bicknell RJ, Brown D, Bowden C, Chapman C, Russell JA: Stimulus-induced depletion of pro-enkephalins, oxytocin and vasopressin and pro-enkephalin interaction with posterior pituitary hormone release in vitro. Neuroendocrinology 1994;60:559–566.
9.
Lindow SW, Hendricks MS, Thompson JW, Van-der Spuy ZM: Effects of morphine administration on the fetal production of oxytocin in labour. Clin Sci (Lond) 1998;95:91–95.
10.
Lindow SW, Van-der-Spuy ZM, Hendricks MS, Nugent FA, Dunne TT: The effect of morphine and naloxone administration on maternal oxytocin concentration in late pregnancy. Clin Endocrinol (Oxf) 1993;39:671–675.
11.
Nathorst-Boos J, Stock S, von Schoultz B: Effects of oophorectomy and estrogen treatment on basal levels and 24-h profiles of oxytocin. Gynecol Endocrinol 1994;8:127–132.
12.
Stock S, Karlsson R, von Schoultz B: Serum profiles of oxytocin during oral contraceptive treatment. Gynecol Endocrinol 1994;8:121–126.
13.
Steinwall M, Akerlund M, Bossmar T, Forsling ML: Osmotically induced release of vasopressin and oxytocin in non-pregnant women – Influence of estrogen and progesterone. Acta Obstet Gynecol Scand 1998;77:983–987.
14.
Marchesi C, Chiodera D, Brusamonti E, Volpi R, Coiro V: Abnormal plasma oxytocin and beta-endorphin levels in alcoholics after short- and long-term abstinence. Prog Neuropsychopharmacol Biol Psychiatry 1997;21:797–807.
15.
Chiodera P, Gnudi A, Rossi G, Camellini L, Caiazza A, Marchesi C, Bianconi L, Volpi R, Coiro V: Dopaminergic but not cholinergic involvement in regulation of hypoglycemia-induced oxytocin release in man. Psychoneuroendocrinology 1989;14:203–208.
16.
Volpi R, Chiodera P, Capretti L, Caffari G, Giuliani N, Caiazza A, Cioro V: Effect of residual endogenous insulin secretion on the abnormal oxytocin response to hypoglycaemia in insulin-dependent diabetes. J Intern Med 1998;244:43–48.
17.
Chiodera P, Volpi R, Capretti L, Caiazza A, Marchesi M, Caffari G, Rossi G, Coiro AV: Oxytocin response to challenging stimuli in elderly men. Regul Pept 1994;51:169–176.
18.
Chiodera P, Volpi R, Coiro V: Inhibitory control of nitric oxide on the arginine-vasopressin and hypoglycaemia in normal men. Neuroreport 1994;5:1822–1824.
19.
Chiodera P, Volpi R, Capretti L, Giuliani N, Caffarri G, Coiro V: Melatonin inhibits oxytocin response to insulin-induced hypoglycemia but not to angiotensin II in normal men. J Neural Transm 1998;105:173–180.
20.
Lang RE, Heil JW, Ganten D, Hermann K, Unger T, Rascher W: Oxytocin unlike vasopressin is a stress hormone in the rat. Neuroendocrinology 1983;37:314–316.
21.
Fruhstorfer B, Pritsch MG, Ott P, Sturm G: Effects of daytime noise load on the sleep-wake cycle and endocrine patterns in man. 24 hours secretion of anterior and posterior pituitary hormones and cortisol. Int J Neurosci 1988;39:211–221.
22.
Sanders G, Freilicher J, Lightman SL: Psychological stress of exposure to uncontrollable noise increases plasma oxytocin in high emotionality women. Psychoneuroendocrinology 1990;15:47–58.
23.
Leckman JF, Goodman WK, North WG, Chappell PB, Price LH, Pauls DL, Anderson GM, Riddle MA, McSwiggan-Hardin M, McDougle CJ, Barr LC, Cohen DJ: Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder: Comparison with Tourette’s syndrom and healthy controls. Arch Gen Psychiatry 1994;51:782–792.
24.
Demitrack MA, Lesem MD, Listwak SJ, Brandt HA, Jimerson DC, Gold PW: CSF oxytocin in anorexia nervosa and bulimia nervosa: Clinical and pathophysiologic considerations. Am J Psychiatry 1990;147:882–886.
25.
Chiodera P, Volpi R, Capretti L, Marchesi C, D’Amato L, De Ferri A, Bianconi I, Coiro V: Effect of estrogen or insulin-induced hypoglycemia on plasma oxytocin levels in bulemia and anorexia nervosa. Metabolism 1991;40:1226–1230.
26.
Martin A, State M, Anderson GM, Kaye WM, Hanchett JM, Conaha CW, North WG, Fleckman J: Cerebrospinal fluid levels of oxytocin in Prader-Willi syndrome: A preliminary report. Biol Psychiatry 1998;44:1349–1352.
27.
Beckmann H, Lang RE, Gattaz WF: Vasopressin-oxytocin in cerebrospinal fluid of schizophrenic patients and normal controls. Psychoneuroendocrinology 1985;10:187–191.
28.
Glorinsky D, Kalogeras KT, Kirch DG, Suddath R, Wyatt RJ: Cerebrospinal fluid oxytocin concentration in schizophrenic patients does not differ from control subjects and is not changed by neuroleptic medication. Schizophr Res 1994;11:273–276.
29.
Warner MD, Gruber N, Peabody CA: Oxytocin and prolactin release after electroconvulsive therapy: A pilot study. Curr Ther Res Clin Exp 1995;56:226–230.
30.
Carmichael MS, Humbert R, Dixen J, Palmisano G, Greenleaf W, Davidson JM: Plasma oxytocin increases in the human sexual response. J Clin Endocrinol Metab 1987;64:27–31.
31.
Carmichael MS, Warburton VL, Dixen J, Davidson JM: Relationships among cardiovascular, muscular and oxytocin responses during human sexual activity. Arch Sex Behav 1994;23:59–79.
32.
Gimpl G, Fahrenholz F: The oxytocin receptor system: Structure, function and regulation. Physiol Rev 2001;81:629–683.
33.
Mitchell BF, Fang X, Wong S: Oxytocin: A paracrine hormone in the regulation of parturition? Rev Reprod 1998;3:113–122.
34.
Kunz G, Noe M, Herbertz M, Leyendecker G: Uterine peristalsis during the follicular phase of the menstrual cycle: Effects of oestroegen, antioestrogen and oxytocin. Hum Reprod Update 1998;4:647–654.
35.
Wildt L, Kissler S, Licht P, Becker W: Sperm transport in the human female genital tract and its modulation by oxytocin as assessed by hysterosalpingoscintigraphy, hysterotonography, electrohysterography and Doppler sonography. Hum Reprod Update 1998;4:655–666.
36.
Bennegard-Eden B, Hahlin M, Kindahl H: Interaction between oxytocin and prostaglandin F2α in human corpus luteum? Hum Reprod 1995;10:2320–2324.
37.
Rettori V, Canteros G, McCann SM: Interaction between NO and oxytocin: Influence on LHRH release. Braz J Med Biol Res 1997;30:453–457.
38.
Hull ML, Reid RA, Evans JJ, Benny PS, Aickin DR: Preovulatory oxytocin administration promotes the onset of the luteinizing hormone surge in human females. Hum Reprod 1995;10:2266–2269.
39.
Gillespie A, Brummer HC, Chard T: Oxytocin release by infused prostaglandin. Br Med J 1972;1:543–544.
40.
Ivell R, Balvers M, Rust W, Bathgate R, Einspanier A: Oxytocin and male reproductive function. Adv Exp Med Biol 1997;424:253–264.
41.
Nicholson HD, Guldenaar SE, Boer GJ, Pickering BT: Testicular oxytocin: Effects of intratesticular oxytocin in the rat. J Endocrinol 1991;130:231–238.
42.
Nicholson HD, Jenkin L: Oxytocin and prostatic function. Adv Exp Med Biol 1995;395:529–538.
43.
Nicholson HD: Oxytocin: A pracrine regulator of prostatic function. Rev Reprod 1996;1:69–72.
44.
Frayne J, Nicholson HD: Localisation of oxytocin receptors in the human and macaque monkey male reproductive tracts: Evidence for a physiological role of oxytocin in the male. Mol Hum Reprod 1998;4:527–532.
45.
Argiolas A: Oxytocin stimulation of penile erection. Pharmacology, site, and mechanism of action. Ann NY Acad Sci 1992;652:194–203.
46.
Harris MC, Jones PM, Robinson IC: Differences in the release of oxytocin into the blood and cerebrospinal fluid following hypothalamic and pituitary stimulation in rats. J Physiol 1981;320:109–110.
47.
Dogterom J, Van Wimersma Greidanus TB, Swabb DF: Evidence for the release of vasopressin and oxytocin into cerebrospinal fluid. Measurements in plasma and CSF of intact and hypophysectomized rats. Neuroendocrinology 1977;24:108–118.
48.
Lidberg L: The effect of Syntocinon on patients suffering from impotence. Pharmakopsychiatr Neuropsychopharmakol 1972;5:187–190.
49.
Lidberg L, Sternthal V: A new approach to the hormonal treatment of impotentia erectionis. Pharmakopsychiatr Neuropsychopharmakol 1977;10:21–25.
50.
Amico JA, Finn FM, Haldar J: Oxytocin and vasopressin are present in human and rat pancreas. Am J Med Sci 1988;296:303–307.
51.
Alszuler N, Hampshire J: Oxytocin infusion increases plasma insulin and glucagon levels and glucose production and uptake in the normal dog. Diabetes 1981;30:112–114.
52.
Knudtzon J: Acute effects of oxytocin and vasopressin on plasma levels of glucagon, insulin and glucose in rabbits. Horm Metab Res 1983;15:103–104.
53.
Stock S, Fastborn J, Bjorkstrand E, Ingerstedt U, Uvnäs-Moberg K: Effect of oxytocin on in vivo release of insulin and glucagon studied by microdialysis in the rat pancreas and autoradiographic evidence for [3H] oxytocin binding sites within the islets of Langerhans. Regul Pept 1990;30:1–13.
54.
Dunning BE, Moltz JH, Fawcett CP: Actions of neurohypophysial peptides on pancreatic hormone release. Am J Physiol 1984;246:E108–E114.
55.
Widmaier EP, Shah PR, Lee G: Interactions between oxytocin, glucagon and glucose in normal and streptozotocin-induced diabetic rats. Regul Pept 1991;34:235–249.
56.
Matthews SG: Hypothalamic oxytocin in the developing ovine fetus: Interaction with pituitary-adrenocortical function. Brain Res 1999;820:92–100.
57.
Paolisso G, Sgambato S, Giugliano D, Pizza G, Tesauro P, Varricchio M, D’Onofrio F: Effects of oxytocin delivery on counter-regulatory hormone response in insulin-dependent (type I) diabetic subjects. Horm Res 1989;31:250–255.
58.
Paolisso G, Pizza G, DeRiu S, Marrazzo G, Sgambato S, Giugliano D, Varricchio M, D’Onofrio F: Effects of oxytocin upon the endocrine pancreas secretion and glucose turnover in normal men. Acta Endocrinol (Copenh) 1990;123:504–510.
59.
Gavrilenko VG, Stadnikov AA, Esipov VK, Mit’kin AF: The use of oxytocin in the combined treatment of suppurative-necrotic lesions of the feet in diabetic patients. Vestnik Khirgii Imeni i-i-Grekova 2000;159:59–62.
60.
Gutkowska J, Jankowski M, Mukaddam- Daher S, McCann SM: Oxytocin is a cardiovascular hormone. Braz J Med Biol Res 2000;33:625–633.
61.
Thibonnier M, Conarty DM, Preston JA, Plesnicher CL, Dweik RA, Erzurum SC: Human vascular endothelial cells express oxytocin receptors. Endocrinology 1999;140:1301–1309.
62.
Coulson CC, Thorp JM, Mayer DC, Cefalo RC: Central hemodynamic effects of oxytocin and interaction with magnesium and pregnancy in the isolated perfused rat heart. Am J Obstet Gynecol 1997;177:91–93.
63.
Jankowski M, Hajjar F, Kawas SA, Mukaddam DS, Hoffman G, McCann SM, Gutkowska J: Rat heart: A site of oxytocin production and action. Proc Natl Acad Sci USA 1998;95:14558–14563.
64.
Gutkowska J, Jankowski M, Lambert C, Mukaddam DS, Zingg HH, McCann SM: Oxytocin releases atrial natriuretic peptide by combining with oxytocin receptors in the heart. Proc Natl Acad Sci USA 1997;94:11704–11709.
65.
Johnstone M: The cardiovascular effects of oxytocic drugs. Br J Anaesth 1972;44:826.
66.
Hendricks CH, Brenner WE: Cardiovascular effect of oxytocin drugs used post partum. Am J Obstet Gynecol 1970;108:751–760.
67.
Stolz-Born G, Widder B, Born J: Vascular effects of oxytocin on human middle cerebral artery determined by transcranial Doppler sonography. Regul Pept 1996;62:37–39.
68.
Ueda T, Yokoyama Y, Irahara M, Aono T: Influence of psychological stress on suckling-induced pulsatile oxytocin release. Obstet Gynecol 1994;84:259–262.
69.
Nakamura H, Itakuara A, Okamura M, Ito M, Iwase A, Nakanishi Y, Okada M, Nagasak T, Mizutami S: Oxytocin stimulates the translocation of oxytocinase of human vascular endothelial cells via activation of oxytocin receptors. Endocrinology 2000;141:4481–4485.
70.
Nagasaka T, Nomura S, Okamura M, Tsujimoto M, Nakazato H, Oiso Y, Nakashima N, Mizutami S: Immunohistochemical localisation of placental leucine aminopeptidase (oxytocinase) in normal human placental, fetal and adult tissues. Reprod Fertil Dev 1997;9:747–753.
71.
Conrad KP, Gellai M, North WG, Valtin H: Influence of oxytocin on renal hemodynamics and sodium excretion. Ann NY Acad Sci 1993;689:346–362.
72.
Ostrowski NL, Lolait SJ: Oxytocin receptor gene expression in female rat kidney. The effect of estrogen. Adv Exp Med Biol 1995;395:329–340.
73.
Haanwinckel MA, Elias LK, Favaretto AL, Gutkowska J, McCann SM, Antunes RJ: Oxytocin mediates atrial natriuretic peptide release and natriuresis after volume expansion in the rat. Proc Natl Acad Sci USA 1995;92:7902–7906.
74.
Soares TJ, Coimbra TM, Martins AR, Pereira AG, Carnio EC, Branco LG, Albuquerque AW, DeNucci G, Favaretto AL, Gutkowska J, McCann SM, Antunes RJ: Atrial natriuretic peptide and oxytocin induce natriuresis by release of cGMP. Proc Natl Acad Sci USA 1999;96:278–283.
75.
Chan WY: Renal prostaglandins and natriuretic action of oxytocin and vasopressin in rats. J Pharmacol Exp Ther 1988;246:603–609.
76.
Sjöquist M, Huang W, Jacobsson E, Skott O, Stricker EM, Sved AF: Sodium excretion and renin secretion after continuous versus pulsatile infusion of oxytocin in rats. Endocrinology 1994;140:2814–2818.
77.
Laversen NH, Birnbaum SJ: Water intoxication associated with oxytocin administration during saline-induced abortion. Am J Obstet Gynecol 1975;121:2–6.
78.
McCarthy MM, McDonald CH, Brooks PJ, Goldman D: An anxiolytic action of oxytocin is enhanced by estrogen in the mouse. Physiol Behav 1996;60:1209–1215.
79.
Windle RJ, Shanks N, Lightman SL, Ingram CD: Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats. Endocrinology 1997;138:2829–2834.
80.
Arletti R, Bertolini A: Oxytocin acts as an antidepressant in two animal models of depression. Life Sci 1987;41:1725–1730.
81.
Klein DF, Skrobolo AM, Garfinkel RS: Preliminary look at the effects of pregnancy on the course of panic disorder. Anxiety 1995;1:227–232.
82.
De Wied D, Gaffori O, Burbach JP, Kovacs GL, Van Ree JM: Structure activity relationship studies with C-terminal fragments of vasopressin and oxytocin on avoidance behaviors of rats. J Pharmacol Exp Ther 1987;241:268–274.
83.
Ibragimov RSh: Influence of neurohypophyseal peptides on the formation of active avoidance conditioned reflex behavior. Neurosci Behav Physiol 1990;20:189–193.
84.
Bruins J, Hijgman R, Van Ree JM: Effect of a single dose of des-glycinamide-[Arg8]vasopressin or oxytocin on cognitive processes in young healthy subjects. Peptides 1992;13:461–468.
85.
Caruso S, Agnello C, Campo MG, Nicoletti F: Oxytocin reduces the activity of N-methyl-D-aspartate receptors in cultured neurons. J Endocrinol Invest 1993;16:921–924.
86.
Dantzer R, Bluthe RM, Koob GF, LeMoal M: Modulation of social memory in male rats by neurohypophyseal peptides. Psychopharmacology (Berl) 1987;91:363–368.
87.
Arletti R, Benelli A, Poggioli R, Luppi P, Menozzi B, Bertolini A: Aged rats are still responsive to the antidepressant and memory improving effects of oxytocin. Neuropeptides 1995;29:177–182.
88.
Popik P, Van Ree JM: Neurohypophyseal peptides and social recognition in rats. Prog Brain Res 1998;119:415–436.
89.
Coldwell JD: Central oxytocin and female sexual behavior. Ann NY Acad Sci 1992;652:166–179.
90.
Insel TR: Oxytocin, a neuropeptide for affiliation: Evidence from behavioral, receptor autoradiographic, and comparative studies. Psychoneuroendocrinology 1992;17:3–35.
91.
Cushing BS, Carter CS: Prior exposure to oxytocin mimics the effects of social contact and facilitates sexual behaviour in females. J Neuroendocrinology 1999;11:765–769.
92.
Melis MR, Argiolas A, Gessa GL: Oxytocin-induced penile erection and yawning: Site of action in the brain. Brain Res 1986;398:259–265.
93.
Argiolas A, Melis MR: The neuropharmacology of yawning. Eur J Pharmacol 1998;343:1–16.
94.
Anderson-Hunt M, Dennerstein L: Increased female sexual response after oxytocin. BMJ 1994;309:929.
95.
Kimura T, Ito Y, Einspanier A, Tohya K, Nobunaga T, Tokugawa Y, Takemura M, Kubota Y, Ivell R, Matsuura N, Saji F, Murata Y: Expression and immunolocalisation of the oxytocin receptor in human lactating and non-lactating mammary glands. Hum Reprod 1998;13:2645–2653.
96.
Ito Y, Kobayashi T, Kimura T, Matsuura N, Wagasugi E, Takeda T, Shimano T, Kubota Y, Nobunaga T, Makino Y, Azuma C, Saji F, Monden M: Investigation of the oxytocin receptor expression in human breast cancer tissue using newly established monoclonal antibodies. Endocrinology 1996;137:773–779.
97.
Copland JA, Jeng Y-J, Strakova Z, Ives KL, Hellmich MR, Soloff MS: Demonstration of functional oxytocin receptors in human breast Hs578T cells and their up-regulation through a protein kinase C-dependent pathway. Endocrinology 1999;140:2258–2267.
98.
Sapino A, Marci L, Tonda L, Bussolati G: Oxytocin enhances myoepithelial cell differentiation and proliferation in the mouse mammary gland. Endocrinology 1993;133:838–842.
99.
Cassoni P, Sapino A, Negro F, Bussolati G: Oxytocin inhibits proliferation of human breast cancer cell lines. Virchows Arch 1994;425:467–472.
100.
Cassoni P, Sapino A, Fortunati N, Munaron L, Chini B, Bussolati G: Oxytocin inhibits the proliferation of MDA-MB 231 human breast cancer cells via cyclic adenosine monophosphate and protein kinase A. Int J Cancer 1997;72:340–344.
101.
Taylor AH, Ang VT, Jenkins JS, Silverlight JJ, Coombes RC, Lugmani YA: Interaction of vasopressin and oxytocin with human breast carcinoma cells. Cancer Res 1990;50:7882–7886.
102.
Cassoni P, Sapino A, Papotti M, Bussolati G: Oxytocin and oxytocin analogue F314 inhibit cell proliferation and tumor growth of rat and mouse mammary carcinomas. Int J Cancer 1996;66:817–820.
103.
Brown DC, Perkowski S: Oxytocin content of the cerebrospinal fluid of dogs and its relationship to pain induced by spinal cord compression. Vet Surg 1998;27:607–611.
104.
Caldwell JD, Mason GA, Stanley DA, Jerdack G, Hruby VJ, Hill P, Prange AJ, Pederson CA: Effects of nonapeptide antagonists on oxytocin- and arginine-vasopressin-induced analgesia in mice. Regul Pept 1987;18:233–241.
105.
Crowley WR, Rodriguez-Sierra JF, Komisaruk BR: Analgesia induced by vaginal stimulation in rats is apparently independent of a morphine-sensitive process. Psychopharmacology (Berl) 1977;54:223–225.
106.
Xu XJ, Wiesenfeld HZ: Is systemically administered oxytocin an analgesic in rats? Pain 1994;57:193–196.
107.
Louvel D, Delvaux M, Felez A, Fioramonti J, Bueno L, Lazorthes Y, Frexinos J: Oxytocin increases thresholds of colonic visceral perception in patients with irritable bowel syndrome. Gut 1996;39:741–747.
108.
Yang J: Intrathecal administration of oxytocin induces analgesia in low back pain involving the endogenous opiate peptide system. Spine 1994;19:867–871.
109.
Madrazo I, Franco BR, Leon MV, Mena I: Intraventricular somatostatin-14, arginine-vasopressin and oxytocin: Analgesic effect in a patient with intractable cancer pain. Appl Neurophysiol 1987;50:427–431.
© 2003 S. Karger AG, Basel
2003
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
